Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00007618 | The Identification of Prognostic Factors of Late Stage Disease, Particularly Those That Are Modifiable, That Might Explain the Worsened Prognosis With Colorectal Cancer Among Veterans. | completed | — | — | US Department of Veterans AffairsFED | 1 | Feb 3, 2011 | clinicaltrials |
| NCT00441311 | Dissemination of Colorectal Cancer Screening to Primary Care Physicians | completed | Phase 4 | 264 | Columbia UniversityOTHER | 1 | Feb 1, 2011 |
| clinicaltrials |
| NCT01286662 | A Cohort Study of Patients Treated With Brachytherapy for Selected Desmoid Patients in Gardner Syndrome | completed | — | 105 | Triemli HospitalOTHER | 0 | Jan 31, 2011 | clinicaltrials |
| NCT00782886 | Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer | completed | — | 75 | Pathfinder TherapeuticsINDUSTRY | 1 | Jan 27, 2011 | clinicaltrials |
| NCT01283802 | Intraoperative Cholangio-Ultrasound in Resective Liver Surgery(IOCUS) | completed | — | 448 | University of MilanOTHER | 1 | Jan 26, 2011 | clinicaltrials |
| NCT00207051 | BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies | completed | Phase 1 | 62 | Bristol-Myers SquibbINDUSTRY | 3 | Jan 25, 2011 | clinicaltrials |
| NCT00113776 | Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Jan 21, 2011 | clinicaltrials |
| NCT00411151 | Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer | completed | Phase 2 | 52 | Johannes Gutenberg University MainzOTHER | 1 | Jan 20, 2011 | clinicaltrials |
| NCT00145314 | FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer | completed | Phase 3 | 571 | The Nordic Colorectal Cancer Biomodulation GroupOTHER | 1 | Jan 14, 2011 | clinicaltrials |
| NCT00191984 | A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 5, 2011 | clinicaltrials |
| NCT00005594 | ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas | completed | Phase 2 | 4 | University of Alabama at BirminghamOTHER | 1 | Jan 4, 2011 | clinicaltrials |
| NCT01269970 | Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy | completed | — | — | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 4, 2011 | clinicaltrials |
| NCT00410579 | Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers | completed | — | 744 | NSABP Foundation IncNETWORK | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01262417 | Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion Formation(SEPRAC2T) | completed | Phase 2 | 60 | Centre Leon BerardOTHER | 1 | Dec 17, 2010 | clinicaltrials |
| NCT01251237 | Study to Assess the Tolerability, Safety and Efficacy of an Adapted Gut Cleansing Solution in Routine Colon Cleansing Prior to Colonoscopies | completed | Phase 2 | 120 | NorgineINDUSTRY | 1 | Dec 1, 2010 | clinicaltrials |
| NCT00228189 | Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients | completed | Phase 1 / Phase 2 | 30 | Radboud University Medical CenterOTHER | 1 | Nov 30, 2010 | clinicaltrials |
| NCT00386828 | Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial | completed | Phase 2 | 43 | British Columbia Cancer AgencyOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT00933816 | Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy(SILIUS) | completed | Phase 1 / Phase 2 | 37 | Kindai UniversityOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT01248663 | Reconstruction Method and Delayed Gastric Emptying After Pancreatic Surgery | completed | N/A | 64 | Medical University of ViennaOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT01135732 | Cytological Evaluation of Biliary Epithelium After Endoscopic Sphincterotomy | completed | — | 56 | University of AthensOTHER | 1 | Nov 16, 2010 | clinicaltrials |
| NCT00192712 | Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 20 | Rambam Health Care CampusOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT00768937 | Sorafenib and Transarterial Chemoembolization for Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 22 | Medical University of ViennaOTHER | 1 | Nov 9, 2010 | clinicaltrials |
| NCT01237132 | East-West Hepatocellular Carcinoma Study Group | completed | — | — | University of MilanOTHER | 0 | Nov 9, 2010 | clinicaltrials |
| NCT00478374 | Sorafenib With TACE to Treat Hepatocellular Carcinoma(S-TACE) | completed | Phase 1 | 21 | University of BernOTHER | 1 | Nov 2, 2010 | clinicaltrials |
| NCT00254137 | Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer. | completed | Phase 2 | 92 | Ludwig-Maximilians - University of MunichOTHER | 0 | Oct 28, 2010 | clinicaltrials |
| NCT01211379 | The FLU-FOBT Program in Primary Care Settings Where Disparities Persist | completed | N/A | 1,372 | University of California, San FranciscoOTHER | 1 | Oct 18, 2010 | clinicaltrials |
| NCT00230646 | Promoting Physical Activity After Colorectal Cancer | completed | Phase 3 | 46 | The Miriam HospitalOTHER | 1 | Oct 5, 2010 | clinicaltrials |
| NCT00902733 | Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer | completed | N/A | 125 | City of Hope Medical CenterOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT01212718 | Response Prediction in Metastasized Colorectal Cancer Using Intratumoral Thymidylate Synthase(FOGT5) | completed | Phase 2 | 168 | University of UlmOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00192842 | Gemcitabine With Curcumin for Pancreatic Cancer | completed | Phase 2 | 17 | Rambam Health Care CampusOTHER | 0 | Sep 22, 2010 | clinicaltrials |
| NCT00471965 | Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients(EACH) | completed | Phase 3 | 371 | SanofiINDUSTRY | 4 | Sep 20, 2010 | clinicaltrials |
| NCT00414492 | Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer | completed | — | 100 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Sep 16, 2010 | clinicaltrials |
| NCT00490685 | Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 142 | Istituto Clinico HumanitasOTHER | 1 | Sep 2, 2010 | clinicaltrials |
| NCT01186081 | Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer | completed | Phase 3 | 240 | Asan Medical CenterOTHER | 1 | Aug 23, 2010 | clinicaltrials |
| NCT00469443 | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC | completed | Phase 3 | 330 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00873353 | Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients(XELTA) | completed | Phase 2 | 32 | Grupo Gallego de Investigaciones OncologicasOTHER | 1 | Aug 18, 2010 | clinicaltrials |
| NCT00415168 | Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer | completed | Phase 2 | 53 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 17, 2010 | clinicaltrials |
| NCT00345761 | Clinical Study of Capecitabine, Oxaliplatin and Bevacizumab in Colorectal Cancer | completed | Phase 1 / Phase 2 | 64 | Chugai PharmaceuticalINDUSTRY | 1 | Aug 16, 2010 | clinicaltrials |
| NCT01181557 | A Questionnaire to Assess the Quality of Life of Rectal Cancer Patients With or Without Stoma | completed | — | 236 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Aug 13, 2010 | clinicaltrials |
| NCT00772083 | Caring for Those Who Share: Improving the Health of Wisconsin Blood Donors | completed | N/A | 400 | Medical College of WisconsinOTHER | 1 | Aug 11, 2010 | clinicaltrials |
| NCT01177371 | High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma | completed | Phase 2 | 13 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 9, 2010 | clinicaltrials |
| NCT00423254 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | completed | Phase 1 | 12 | Mannkind CorporationINDUSTRY | 1 | Aug 3, 2010 | clinicaltrials |
| NCT00294840 | Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment | completed | — | 70 | Rambam Health Care CampusOTHER | 1 | Jul 29, 2010 | clinicaltrials |
| NCT00373737 | Microarray Analysis of Gene Expression in Liver Tumors | completed | — | 300 | Stanford UniversityOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT01170845 | Effect of Neutrophil Elastase Inhibitor on Lung Injury After Esophagectomy(NEIE) | completed | N/A | 31 | Yokohama City University Medical CenterOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00648102 | Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer(CDX1307-02) | completed | Phase 1 | 36 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00709462 | A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer (CDX 1307-01) | completed | Phase 1 | 48 | Celldex TherapeuticsINDUSTRY | 1 | Jul 26, 2010 | clinicaltrials |
| NCT00138060 | Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants | completed | Phase 4 | 71 | Institut de Recherche Clinique sur les Cancers et le SangOTHER | 1 | Jul 20, 2010 | clinicaltrials |
| NCT01163812 | Clinical Trial for Laparoscopic D2 Gastrectomy(NCC181) | completed | Phase 2 | 64 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 19, 2010 | clinicaltrials |
| NCT00583934 | Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial? | completed | — | 19 | University of California, DavisOTHER | 1 | Jul 13, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Feb 3, 2011source: clinicaltrials